Canada Markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7653-0.0007 (-0.09%)
At close: 04:00PM EST
0.7700 +0.00 (+0.61%)
After hours: 07:55PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.65
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.3100
52 Week Low 30.7500
50-Day Moving Average 30.8354
200-Day Moving Average 31.0160

Share Statistics

Avg Vol (3 month) 3432.31k
Avg Vol (10 day) 3294.65k
Shares Outstanding 5126.62M
Implied Shares Outstanding 6N/A
Float 8118.83M
% Held by Insiders 10.04%
% Held by Institutions 125.03%
Shares Short (Oct 13, 2022) 410.6M
Short Ratio (Oct 13, 2022) 426.5
Short % of Float (Oct 13, 2022) 48.37%
Short % of Shares Outstanding (Oct 13, 2022) 48.37%
Shares Short (prior month Sept 14, 2022) 411.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 19, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Apr 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-9.53%
Return on Equity (ttm)-15.66%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.32M
Net Income Avi to Common (ttm)-21.49M
Diluted EPS (ttm)-1.9750
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)125.54M
Total Cash Per Share (mrq)0.99
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)35.19
Book Value Per Share (mrq)0.56

Cash Flow Statement

Operating Cash Flow (ttm)-17.55M
Levered Free Cash Flow (ttm)-8.84M